Abstract
This work reports the experience with use of continuous subcutaneous insulin infusion (CSII) in 112 type 1 diabetic patients followed up for 7 years and previously treated with multiple daily insulin injections (MDII). A retrospective, observational study in 112 patients with diabetes mellitus treated with CSII from 2005 to 2012, previously treated with MDII and receiving individualized diabetic education with a specific protocol. Variables analyzed included: prevalence of the different indications of pump treatment; mean annual HbA1c and fructosamine values before and after CSII treatment; and hypoglycemia frequency and symptoms. The most common reason for pump treatment was brittle diabetes (74.1%), followed by frequent or severe hypoglycemia or hypoglycemia unawareness (44.6%). Other indications were irregular food intake times for professional reasons (20.2%), dawn phenomenon (15.7%), pregnancy (12.3%), requirement of very low insulin doses (8.9%), and gestational diabetes (0.9%). HbA1c decreased by between 0.6% and 0.9%, and fructosamine by between 5.1% and 12.26%. Nine percent of patients experienced hypoglycemia weekly, 24% every two weeks, and 48% monthly. No hypoglycemia occurred in 19% of patients. Only 10% had neurog...Continue Reading
References
Jan 28, 1978·British Medical Journal·J C PickupK G Alberti
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Sep 28, 2001·Diabetes Care·E TsuiB Zinman
Mar 5, 2002·Diabetes Care·John Pickup, Harry Keen
May 17, 2002·Journal of Pediatric Endocrinology & Metabolism : JPEM·K RaileH P Schwarz
Sep 5, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·R LinkeschovaM Spraul
Oct 29, 2002·Diabetes Care·J Hans DeVriesUNKNOWN Dutch Insulin Pump Study Group
May 8, 2003·JAMA : the Journal of the American Medical Association·Dawn E DeWitt, Irl B Hirsch
Sep 29, 2004·Diabetes Care·Max K BulsaraTimothy W Jones
Oct 27, 2004·Diabetes Care·Ravi RetnakaranBernard Zinman
Mar 1, 2005·Diabetes Care·Irl B HirschUNKNOWN Insulin Aspart CSII/MDI Comparison Study Group
Mar 21, 2008·Diabetologia·K JeitlerA Siebenhofer
Dec 18, 2008·The Journal of Clinical Endocrinology and Metabolism·Mitra M FatourechiVictor M Montori
Jan 28, 2009·Diabetes/metabolism Research and Reviews·Daniela BruttomessoAldo Baritussio
Sep 1, 2011·Diabetes Research and Clinical Practice·Triantafillos Didangelos, Fotios Iliadis
Apr 27, 2012·The New England Journal of Medicine·John C Pickup
Jul 11, 2012·Annals of Internal Medicine·Hsin-Chieh YehSherita Hill Golden
Citations
Aug 8, 2014·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Matthew F BouchonvilleDavid S Schade
Dec 30, 2014·Diabetes Care·Shazli AzmiRayaz A Malik
Apr 22, 2017·Diabetic Medicine : a Journal of the British Diabetic Association·U AnyanwaguE G Wilmot
Jun 22, 2017·Diabetic Medicine : a Journal of the British Diabetic Association·L LeelarathnaM K Rutter
May 31, 2018·Diabetes Technology & Therapeutics·Sylvie PicardBruno Guerci
Aug 12, 2014·Nature Reviews. Drug Discovery·Samir MitragotriRobert Langer
Nov 20, 2016·Diabetes Technology & Therapeutics·Alex Ramirez-RinconJosé Fernando Botero
Jul 28, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·P Beato-VíboraP Choudhary
Jul 25, 2017·Langenbeck's Archives of Surgery·Ajay V MakerUNKNOWN Diabetes Control and Complications Trial (DCCT) Research Group
Feb 3, 2020·Endocrinología, Diabetes Y Nutrición·Jesus Moreno-FernandezFrancisco Javier Gómez-Romero